The Alzheimer's Association International Conference is the world's largest forum for the dementia research community. London, UK, and online.

Purpose Cerebrospinal fluid (CSF) biomarkers are increasingly used to support Alzheimer’s disease (AD) diagnosis: Alzheimer’s Disease continuum (ADc) is defined by abnormal amyloid-beta (Aβ), while Su...

Within the framework of pursuing an advanced public policy based on research with relevance to the community, the production of knowledge, and the development of solutions to address contemporary chal...

Em entrevista exclusiva ao HealthNews, o Professor Tiago Gil Oliveira, galardoado com o Prémio Bial de Medicina Clínica 2024, professor associado na Escola de Medicina da Universidade do Minho, neuror...

Introduction Amygdala-predominant Lewy body (LB) pathology occurs frequently in association with advanced Alzheimer’s disease (AD). Its clinical significance is not yet fully clarified. We investigate...

INTRODUCTION The presence and interaction of multiple comorbid neuropathologies are a major contributor to the worldwide dementia burden. METHODS We analyzed 1183 subjects from the National Alzhei...

The 11th European Academy of Neurology congress will be on 21-24 June 2025, in Helsinki, Finland

<p><span>No Essencial desta sexta-feira, olhamos para a investigação portuguesa sobre a doença de Alzheimer. É a causa mais frequente das demências, que se estima atinjam mais de 50 milhões de pessoas...

INTRODUCTION Alzheimer's disease (AD) co-pathology with Lewy bodies (LB) is frequent and influences clinical manifestations and outcomes. Its significance in primary age-related tauopathy (PART) is ...

The neurophysiological processes regulated by meningeal lymphatic function remain unclear. das Neves et al. showed that meningeal lymphatic dysfunction leads to loss of mature oligodendrocytes and dem...